Evaluation of the gastrointestinal tract in juvenile systemic sclerosis: the paediatric gastroenterologist

Amornluck Krasaelap1, Rachel E Borlack2, Javier Garcia-Marin2

  • 1Division of Gastroenterology and Hepatology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.

Insights

Gastrointestinal (GI) disease affects many children with juvenile systemic sclerosis (jSSc), impacting their quality of life. Early diagnosis and multidisciplinary care are crucial for managing jSSc GI complications.

Area of Science:

  • Pediatric Rheumatology
  • Gastroenterology
  • Systemic Sclerosis Research

Background:

  • Gastrointestinal (GI) involvement is common in juvenile systemic sclerosis (jSSc), affecting 42-78% of pediatric patients.
  • GI complications significantly impair quality of life and increase morbidity and mortality in jSSc.
  • The pathogenesis involves immune-mediated vascular, mucosal, and neuromuscular damage to the GI tract, leading to diverse clinical presentations.

Purpose of the Study:

  • To review the clinical presentation and diagnostic strategies for upper and lower GI disease in jSSc.
  • To emphasize the challenges in diagnosing and monitoring GI disease in this population.
  • To highlight the importance of a high index of suspicion and multidisciplinary collaboration.

Main Methods:

  • Review of clinical scenarios across different GI segments (oropharynx/esophagus, stomach/small bowel, colon/anorectum).
  • Discussion of diagnostic work-up for GI manifestations in jSSc.
  • Emphasis on the multifactorial diagnostic challenges, including non-specific symptoms and testing limitations.

Main Results:

  • GI disease presents heterogeneously in jSSc, with variable symptoms, severity, and progression.
  • Diagnosis and monitoring of GI disease in jSSc are challenging due to non-specific symptoms and diagnostic limitations.
  • Effective management requires timely evaluation, appropriate diagnostic testing, and collaborative care.

Conclusions:

  • Assessing GI disease in jSSc necessitates a high level of clinical suspicion.
  • Prompt evaluation and accurate diagnostic testing are essential for optimal patient outcomes.
  • Multidisciplinary collaboration is paramount in managing GI complications of jSSc.

Related Concept Videos

Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...